Literature DB >> 27793664

Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling.

Zheng Xu1, Zhengdong Hong2, Ming Ma3, Xiuxia Liu4, Leifeng Chen5, Chuqian Zheng5, Xiaoqing Xi2, Jianghua Shao6.   

Abstract

Rho-associated coiled-coil forming protein kinase 2 (Rock2), as a key effector of the small GTPase RhoA, is involved in tumor development. Scavenger receptor class A member 5 (SCARA5) is an important regulator of biological processes in cancer cells. However, the roles and relationship of Rock2 and SCARA5 in renal cell carcinoma (RCC) remain unclear. In this study, we found that Rock2 expression was markedly increased in clinical RCC tissues compared with that in adjacent non-cancerous tissues. High expression of Rock2 was inversely correlated with patient survival in RCC, which indicated that Rock2 may be a prognostic marker in human RCC. In addition, Rock2 knockdown increased SCARA5 expression and suppressed RCC cell proliferation both in vitro and in vivo. Furthermore, we found that the β-catenin/TCF4 pathway contributed to the effect of Rock2 on SCARA5-mediated RCC proliferation. Taken together, these results suggest that this newly identified Rock2-β-catenin/TCF4-SCARA5 axis will provide novel insight into the understanding of the regulatory mechanisms of proliferation in human RCC.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Proliferation; Renal cell carcinoma; Rock2; SCARA5

Mesh:

Substances:

Year:  2016        PMID: 27793664     DOI: 10.1016/j.bbrc.2016.10.097

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.

Authors:  Hongliang Liu; Junwen Hu; Hua Pan; Dilai Luo; Mingwen Huang; Wei Xu
Journal:  Dig Dis Sci       Date:  2017-11-30       Impact factor: 3.199

2.  Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation.

Authors:  Weiyin Gao; Shouhua Zhang; Li Guorong; Queling Liu; Anyi Zhu; Fu Gui; Yan Zou; Yiguo Wu; Yang Luo; Zhengdong Hong
Journal:  Cell Cycle       Date:  2022-01-02       Impact factor: 4.534

3.  Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.

Authors:  Kawuli Jumai; Tangjuan Zhang; Bingzhang Qiao; Julaiti Ainiwaer; Haiping Zhang; Zhichao Hou; Idris Awut; Madinyat Niyaz; Liwei Zhang; Ilyar Sheyhidin
Journal:  J Immunol Res       Date:  2022-06-17       Impact factor: 4.493

4.  ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation.

Authors:  Xueqiang Deng; Xuan Yi; Da Huang; Peng Liu; Leifeng Chen; Yunyan Du; Liang Hao
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  MicroRNA-139-5p Inhibits Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil-Containing Protein Kinase 2 in Ovarian Cancer.

Authors:  Yanli Wang; Jia Li; Chunling Xu; Xiaomeng Zhang
Journal:  Oncol Res       Date:  2017-06-14       Impact factor: 5.574

6.  SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.

Authors:  Jinwei Wang; Sha Wang; Lu Chen; Jia Tan
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

7.  miR-5590-3p inhibits the proliferation and metastasis of renal cancer cells by targeting ROCK2 to inhibit proliferation, migration and invasion.

Authors:  Queling Liu; Anyi Zhu; Weiyin Gao; Fu Gui; Yan Zou; Xiaocheng Zhou; Zhengdong Hong
Journal:  Oncol Lett       Date:  2022-09-08       Impact factor: 3.111

8.  SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.

Authors:  Hongliang Liu; Junwen Hu; Ran Wei; Longfei Zhou; Hua Pan; Hongchao Zhu; Mingwen Huang; Jun Luo; Wei Xu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-18

9.  Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4.

Authors:  Jing-Meng Hu; Li-Jie He; Peng-Bo Wang; Yan Yu; Ya-Ping Ye; Li Liang
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.